Absolute risk of cardiovascular disease events, and blood pressure- and lipid-lowering therapy in Australia

QR Code

Absolute risk of cardiovascular disease events, and blood pressure- and lipid-lowering therapy in Australia

Bibliographic Details
Main Authors:	Dhaliwal, Satvinder, Welborn, T.
Format:	Journal Article
Published:	Australasian Medical Publishing 2017
Online Access:	http://hdl.handle.net/20.500.11937/62871

Similar Items

Short- and long-term association of lipid-lowering drug treatment and cardiovascular disease by estimated absolute risk in the Second Australian National Blood Pressure study
by: Ho, C., et al.
Published: (2018)

Blood-pressure lowering in intermediate-risk persons without cardiovascular disease
by: Lonn, Eva M., et al.
Published: (2016)

Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
by: Lonn, E., et al.
Published: (2016)

Central obesity and cigarette smoking are key determinants of cardiovascular disease deaths in Australia: A public health perspective
by: Dhaliwal, Satvinder, et al.
Published: (2009)

SHOULD YOU LEAVE A LEGACY? POTENTIAL EFFECTS OF DELAYED BLOOD PRESSURE LOWERING PHARMACOTHERAPY IN INDIVIDUALS STRATIFIED BY ABSOLUTE CARDIOVASCULAR DISEASE RISK
by: Ho, C., et al.
Published: (2016)

Legacy Effect of Delayed Blood Pressure-Lowering Pharmacotherapy in Middle-Aged Individuals Stratified by Absolute Cardiovascular Disease Risk: Protocol for a Systematic Review.
by: Ho, C., et al.
Published: (2017)

Central Obesity and Multivariable Cardiovascular Risk as Assessed by the Framingham Prediction Scores
by: Dhaliwal, Satvinder, et al.
Published: (2009)

Blood-pressure and cholesterol lowering in persons without cardiovascular disease
by: Yusuf, Salim, et al.
Published: (2016)

Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease
by: Yusuf, S., et al.
Published: (2016)

Obesity as Assessed by Body Adiposity Index and Multivariable Cardiovascular Disease Risk
by: Dhaliwal, Satvinder, et al.
Published: (2014)

Effectiveness of blood pressure-lowering drug treatment by levels of absolute risk: Post hoc analysis of the Australian National Blood Pressure Study
by: Ho, C., et al.
Published: (2018)

Independent external validation of cardiovascular disease mortality in women utilising Framingham and SCORE risk models: a mortality follow-up study
by: Goh, Louise, et al.
Published: (2014)

The effect of taking blood pressure lowering medication at night on cardiovascular disease risk. A systematic review
by: Ho, Chau L.B., et al.
Published: (2021)

The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: Meta-analysis of randomized trials
by: Czernichow, S., et al.
Published: (2011)

POST HOC ANALYSIS OF THE EFFECTIVENESS OF BLOOD PRESSURE-LOWERING DRUG TREATMENT BY LEVELS OF ABSOLUTE RISK IN THE ANBP STUDY
by: Ho, C., et al.
Published: (2017)

Anthropometric measurements of general and central obesity and the prediction of cardiovascular disease risk in women: a cross-sectional study
by: Goh, Louise, et al.
Published: (2014)

Update on trials examining effects of night-time blood pressure lowering drug treatment on prevention of cardiovascular disease
by: Ho, Chau Le Bao, et al.
Published: (2022)

Lipid and blood pressure lowering effects of Mikania micrantha through enzymatic inhibition
by: Shafie, Nurul Husna, et al.
Published: (2023)

Lipid and blood pressure lowering potential of Mikania micrantha through enzymatic inhibition
by: Shafie, Nurul Husna, et al.
Published: (2020)

Recreational Physical Activity as an Independent Predictor of Multivariable Cardiovascular Disease Risk
by: Dhaliwal, Satvinder, et al.
Published: (2013)

Ethnicity and the association between anthropometric indices of obesity and cardiovascular risk in women: a cross-sectional study
by: Goh, Louise, et al.
Published: (2014)

Analysis of primary prevention services for cardiovascular disease in Australia's community pharmacies
by: Joyce, Andrew, et al.
Published: (2007)

Inertia or inaction? blood pressure management and cardiovascular risk in diabetes
by: Owen, A., et al.
Published: (2009)

Pred/iction of cardiovascular events in subjects in the second australian national blood pressure study
by: Nelson, M., et al.
Published: (2010)

Cholesterol lowering in intermediate-risk persons without cardiovascular disease
by: Yusuf, Salim, et al.
Published: (2016)

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
by: Yusuf, S., et al.
Published: (2016)

Modification of the effect of lipids on the risk of cardiovascular diseases by cigarette smoking
by: Huxley, Rachel, et al.
Published: (2010)

Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: a meta-analysis of randomised trials.
by: Blood Pressure Lowering Treatment Trialists' Collaboration, et al.
Published: (2015)

Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: The atherosclerosis risk in communities study
by: Lopez, F., et al.
Published: (2012)

Blood pressure variables and cardiovascular risk: New findings from advance
by: Kengne, A., et al.
Published: (2009)

Cigarette smoking, systolic blood pressure, and cardiovascular diseases in the asia-pacific region
by: Nakamura, K., et al.
Published: (2008)

Utility of established cardiovascular disease risk score models for the 10-year prediction of disease outcomes in women
by: Goh, Louise, et al.
Published: (2013)

Measurement error and ethnic comparisons of measures of abdominal obesity
by: Dhaliwal, Satvinder, et al.
Published: (2009)

Blood pressure lowering mechanisms of Kadukmy™ in essential hypertension
by: Mohd Zainudin, Maizura, et al.
Published: (2019)

Novel blood pressure-lowering effect of spathulenol in rats
by: Raslan Ain-Fatin,, et al.
Published: (2024)

Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance
by: Cooper, Angela, et al.
Published: (2008)

Long-term Effects of Statins, Blood Pressure-Lowering, and Both on Erectile Function in Persons at Intermediate Risk for Cardiovascular Disease: A Substudy of the Heart Outcomes Prevention Evaluation-3 (HOPE-3) Randomized Controlled Trial
by: Joseph, P., et al.
Published: (2018)

Fiction absolute and ethics: Tom Wolfe‘s back to blood
by: Jamshidian, Sahar, et al.
Published: (2014)

Association of ABO blood group and leptin level on Framingham risk score in determining cardiovascular disease risk
by: Md Noor, Sabariah, et al.
Published: (2024)

IMPACT OF EXCESS WEIGHT ON THE RELATIONSHIP BETWEEN BLOOD PRESSURE AND CARDIOVASCULAR DISEASE: THE ASIA PACIFIC COHORT STUDIES COLLABORATION
by: Tsukinoki, R., et al.
Published: (2011)